| Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming FO Adeshakin, AO Adeshakin, LO Afolabi, D Yan, G Zhang, X Wan Frontiers in Oncology 11, 626577, 2021 | 170 | 2021 |
| Essential Oil of Grape Fruit (Citrus paradisi) Peels and Its Antimicrobial Activities WO Okunowo, O Oyedeji, LO Afolabi, E Matanmi Scientific Research Publishing, 2013 | 127 | 2013 |
| Lipid metabolic pathways confer the immunosuppressive function of myeloid-derived suppressor cells in tumor D Yan, AO Adeshakin, M Xu, LO Afolabi, G Zhang, YH Chen, X Wan Frontiers in immunology 10, 1399, 2019 | 106 | 2019 |
| Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy AO Adeshakin, W Liu, FO Adeshakin, LO Afolabi, M Zhang, G Zhang, ... Cellular immunology 362, 104286, 2021 | 74 | 2021 |
| Genetic reprogramming for NK cell cancer immunotherapy with CRISPR/Cas9 LO Afolabi, AO Adeshakin, MM Sani, J Bi, X Wan Immunology 158 (2), 63-69, 2019 | 55 | 2019 |
| Artificial intelligence and machine learning in cancer research: a systematic and thematic analysis of the top 100 cited articles indexed in Scopus database IH Musa, LO Afolabi, I Zamit, TH Musa, HH Musa, A Tassang, ... Cancer Control 29, 10732748221095946, 2022 | 29 | 2022 |
| Emerging roles of tripartite motif-containing family proteins (TRIMs) in eliminating misfolded proteins L Zhang, LO Afolabi, X Wan, Y Li, L Chen Frontiers in Cell and Developmental Biology 8, 802, 2020 | 29 | 2020 |
| Nutritional value of Rhynchophorus phoenicis (F.) larvae, an edible insect in Nigeria WO Okunowo, AM Olagboye, LO Afolabi, AO Oyedeji African Entomology 25 (1), 156-163, 2017 | 24 | 2017 |
| Synergistic tumor cytolysis by NK cells in combination with a pan-HDAC inhibitor, panobinostat LO Afolabi, J Bi, X Li, AO Adeshakin, FO Adeshakin, H Wu, D Yan, L Chen, ... Frontiers in immunology 12, 701671, 2021 | 22 | 2021 |
| TRIM family proteins: roles in proteostasis and neurodegenerative diseases Y Zhu, LO Afolabi, X Wan, JS Shim, L Chen Open biology 12 (8), 220098, 2022 | 21 | 2022 |
| Exploiting the CRISPR‐Cas9 gene‐editing system for human cancers and immunotherapy LO Afolabi, MO Afolabi, MM Sani, WO Okunowo, D Yan, L Chen, Y Zhang, ... Clinical & translational immunology 10 (6), e1286, 2021 | 19 | 2021 |
| A natural product, Piperlongumine (PL), increases tumor cells sensitivity to NK cell killing LO Afolabi, J Bi, L Chen, X Wan International Immunopharmacology 96, 107658, 2021 | 15 | 2021 |
| Pharmacological significance of MitoQ in ameliorating mitochondria-related diseases LA Sulaimon, LO Afolabi, RA Adisa, AG Ayankojo, MO Afolabi, ... Advances in Redox Research 5, 100037, 2022 | 13 | 2022 |
| Mechanisms for modulating anoikis resistance in cancer and the relevance of metabolic reprogramming. Front Oncol. 2021; 11: 626577 FO Adeshakin, AO Adeshakin, LO Afolabi, D Yan, G Zhang, X Wan | 12 | 2021 |
| Assessment of the Microbiological Qualities of Locally and Industrially Produced Yoghurt in Lagos LO Afolabi, MO Adelowo, HA Onilude Dutse Journal of Pure and Applied Sciences 3 (1), 188-200, 2017 | 9 | 2017 |
| GC-MS analysis and antimicrobial properties of methanolic extracts of the Marine Algae Skeletonema costatum and Chaetoceros spp. WO Okunowo, LO Afolabi, IE Umunnakwe, AO Oyedeji, JA Ilesanmi Biokemistri 28 (1), 24-24, 2016 | 9 | 2016 |
| Natural compounds, optimal combination of brusatol and polydatin promote anti-tumor effect in breast cancer by targeting nrf2 signaling pathway J Li, J Zhang, Y Zhu, LO Afolabi, L Chen, X Feng International Journal of Molecular Sciences 24 (9), 8265, 2023 | 8 | 2023 |
| Antimicrobial, Antioxidant Potential and Chemical Composition of the Methanolic Extracts of Spirogyra setiformis and Navicula species WO Okunowo, AO Oyedeji, JA Ilesanmi, LO Afolabi, IE Umunnakwe Journal of Scientific Research and Development 17 (1), 15-20, 2018 | 8 | 2018 |
| Suppression of the protein quality control system by TRIM30a sensitizes tumor to NK cell immune surveillance L Afolabi, J Bi, X Yang, X Wan EUROPEAN JOURNAL OF IMMUNOLOGY 49, 461-461, 2019 | 6 | 2019 |
| Regulation of lipid accumulation-induced ROS in myeloid-derived suppressor cells via targeting fatty-acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy AO Adeshakin, W Liu, FO Adeshakin, LO Afolabi, M Zhang, G Zhang, ... BioRxiv, 2020.09. 28.316091, 2020 | 5 | 2020 |
Adeleye O. AdeshakinSt. Jude Children's Research Hospital, Tennessee, USA在 stjude.org 的电子邮件经过验证
